(Q34715426)

4 August 2017

1 reference

title

Type 1A diabetes mellitus-associated autoimmunity (English)

1 reference

4 August 2017

George S Eisenbarth

1 reference

4 August 2017

Edwin Liu

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Endocrinology and Metabolism Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

391-410, vii-viii

1 reference

An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Polyglandular autoimmune syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Recruitment in NHLBI population-based studies and randomized clinical trials: data analysis and survey results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA type and occurrence of disease in familial polyglandular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

A family study of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

High prevalence of diabetes in an urban population in south India

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Clinical aspects of coeliac disease in children with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Insulin-dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Selective IgA deficiency and coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoimmune thyroid disorders and coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The genetics of Graves' disease: HLA and disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Prevalence and clinical significance of gliadin antibodies in healthy children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The humoral immune system in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Gliadin antibodies in adult insulin-dependent diabetes--autoimmune and immunogenetic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Identification of tissue transglutaminase as the autoantigen of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Celiac disease in the general population: should we treat asymptomatic cases?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Transglutaminase antibodies in children with a genetic risk for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Frequency and clinical pattern of celiac disease among siblings of celiac children.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

High Prevalence of Celiac Disease in Patients with Type 1 Diabetes Detected by Antibodies to Endomysium and Tissue Transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Diagnostic value of serological markers for celiac disease in diabetic children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Antibodies to tissue transglutaminase C in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Development of celiac disease-associated antibodies in offspring of parents with type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Genetic Factors in Autoimmune Thyroid Disease Analyzed by Restriction Fragment Length Polymorphisms of Candidate Genes*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA Associations with Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

A population-based study of Graves' disease in Danish twins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Eighty-six cases of Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The natural history of adrenal function in autoimmune patients with adrenal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Selective IgA deficiency in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Central MHC genes, IgA deficiency and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Development of a common variable immunodeficiency in IgA-deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Celiac disease and selective immunoglobulin A deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Prevalence and diagnosis of celiac disease in IgA-deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA-A, B, Cw and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

High-resolution DNA typing in immunoglobulin A deficiency confirms a positive association with DRB1*0301, DQB1*02 haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Family and linkage study of selective IgA deficiency and common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Frequency of Multiple Sclerosis in Menorca, Balearic Islands, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Incidence of multiple sclerosis in Bagheria City, Sicily, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

A population-based study of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The British Isles survey of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

A population-based study of multiple sclerosis in twins: update.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

An association between multiple sclerosis and type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Histocompatibility antigens in childhood-onset arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Prevalence of celiac disease in patients with juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Autoimmunity in congenital rubella syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Type 1A diabetes induced by infection and immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Immunization with gastric H+/K(+)-ATPase induces a reversible autoimmune gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900017-2

7 January 2021

10.1016/S0889-8529(01)00017-2

Identifiers

DOI

1 reference

4 August 2017

1 reference